Skip to content

Efficacy of 8.4% sodium bicarbonate in adult patients with closed head injuries and intracranial hypertension.

Efficacy of 8.4% sodium bicarbonate in adult patients with closed head injuries and intracranial hypertension.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-000219-14-GB
Enrollment
Unknown
Registered
2008-01-25
Start date
2008-03-19
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Raised intracranial pressure after severe head injury. MedDRA version: 9.1 Level: LLT Classification code 10022764 Term: Intracranial hypertension

Interventions

Trade Name: Sodium Bicarbonate BP 8.4% Polyfusor B Product Name: Sodium Bicarbonate BP 8.4% Polyfusor B Pharmaceutical Form: Intravenous infusion

Sponsors

North Bristol NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients in Frenchay Hospital intensive care unit who are intubated, ventilated and sedated after a severe head injury will be considered for enrollment in the trial. They will all have continuous intracranial pressure monitoring in situ and will be at risk of raised intracranial pressure. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Patients aged under 16 years will be excluded. Patients with an initial serum sodium concentration greater than 155mmol/l will be excluded. Patients with concurrent respiratory disease that interferes with the maintenance of a normal arterial carbon dioxide tension will be excluded. Patients with a severe pre-existing severe metabolic alkalosis will be excluded.

Design outcomes

Primary

MeasureTime frame
Main Objective: The main objective of the trial is to establish the ability of 8.4%sodium bicarbonate to lower intracranial pressure below 20mmHg in patients with head injuries and raised intracranial pressure (i.e intracranial pressure above 20mmHg). The duration of any fall in intracranial pressure will also be recorded.;Secondary Objective: The secondary objective of the trial is to establish the effect of 8.4%sodium bicarbonate on the acid/base status of patient's to which it is administered.;Primary end point(s): The primary end point is a fall in intracranial pressure to below 20 mmHg after treatment with 8.4%sodium bicarbonate.

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026